Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
33.00
+0.16 (0.49%)
Sep 11, 2025, 10:50 AM - Market open
Tvardi Therapeutics Market Cap
Tvardi Therapeutics has a market cap or net worth of $309.46 million as of September 11, 2025. Its market cap has increased by 1,546.04% in one year.
Market Cap
309.46M
Enterprise Value
267.21M
1-Year Change
1,546.04%
Ranking
Category
Stock Price
$33.00
Market Cap Chart
Since January 31, 2014, Tvardi Therapeutics's market cap has increased from $282.00M to $309.46M, an increase of 9.74%. That is a compound annual growth rate of 0.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2025 | 298.40M | 965.71% |
| Dec 31, 2024 | 28.00M | -30.86% |
| Dec 29, 2023 | 40.50M | -92.98% |
| Dec 30, 2022 | 577.10M | -11.37% |
| Dec 31, 2021 | 651.10M | -13.65% |
| Dec 31, 2020 | 754.00M | 0.27% |
| Dec 31, 2019 | 752.00M | 46.65% |
| Dec 31, 2018 | 512.80M | 28.49% |
| Dec 29, 2017 | 399.10M | 57.44% |
| Dec 30, 2016 | 253.50M | -44.78% |
| Dec 31, 2015 | 459.10M | 102.16% |
| Dec 31, 2014 | 227.10M | -19.47% |
| Jan 31, 2014 | 282.00M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 677.45B |
| Johnson & Johnson | 423.36B |
| AbbVie | 373.87B |
| UnitedHealth Group | 314.07B |
| AstraZeneca | 250.26B |
| Novo Nordisk | 244.96B |
| Novartis AG | 244.56B |
| Abbott Laboratories | 225.15B |